Ocrelizumab: External Resorption and Implant Treatment?
Last Updated: Apr 09, 2020
I have two patients who have been taking ocrelizumab infusions who have developed medication induced osteonecrosis of the jaw. I have a patient with multiple sclerosis who is also taking ocrelizumab infusions who has external resorption on the distal of her upper right first premolar. I have declined to offer implant treatment for fear of possible medication induced osteonecrosis of the jaw. I would appreciate options and views as to what can be done for her.
> Editor’s note: Ocrelizumab, sold under the brand name Ocrevus, is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug. It was approved by the FDA in March 2017, as a treatment for multiple sclerosis Learn more
22 Comments on Ocrelizumab: External Resorption and Implant Treatment?
Mark Bourcier DMD
04/09/2020
John Fazio DMD
04/09/2020
Jerry
04/09/2020
John Fazio DMD
04/09/2020
Doc B
04/09/2020
Dr Dale Gerke, BDS, BScDe
04/09/2020
Rand
04/09/2020
jerry schwartz,dds
04/09/2020
Rand
04/09/2020
Timothy C Carter
04/09/2020
Dr Indraniil Roy
04/09/2020
Dr Indraniil Roy
04/09/2020
Gopianandan
04/09/2020
Rand
04/09/2020
jerry schwartz,dds
04/09/2020
roadkingdoc
04/10/2020
Matt Helm DMD
04/10/2020
Dr.K
04/10/2020
DrBead
04/10/2020
Rand
04/11/2020
Dr Saad
04/13/2020
Featured Products
Classic 50/50 Mix
Promotes osteoconduction
Provides structural integrity
Convenient Syringe!
50/50 Cortical/Cancellous
Available in 3 sizes.
Eliminate hassle of mixing particulate grafts
Sold in packs of 5 or packs of 10.
Proven safe, and clinically effective
Resorbable collagen membrane derived from purified porcine pericardium
Fast hydration and excellent tensile strength
Good adaptation to various defects
Excellent tear function and duration
100% allograft
Eliminates mixing hassle
Moldable after hydration
mark
04/09/2020